Sentry expands specialty pharmacy capabilities via new partnership with Avella

Sentry expands specialty pharmacy capabilities via new partnership with Avella

March 5th, 2015
Sentry has just entered a new partnership with Avella Specialty Pharmacy, one of the nation's leading specialty pharmacies, known for high-touch customer service. This collaboration will allow both organizations to leverage their strengths in order to better serve covered entities participating in the 340B drug discount program.

Seven steps to recertification

Seven steps to recertification

February 17th, 2015
Recertification for all FQHCs and other non-hospital covered entities (with the exception of Title X family planning centers) must be completed by March 11, 2015. Recertification for these entities follows a separate timeline from 340B hospital recertification, which takes place later in the year.

We’re #1!

We’re #1!

January 30th, 2015
Sentry Data Systems, Inc. is pleased to announce that our Sentinel product has earned the distinction of 2014 KLAS Category Leader for 340B Management Systems in the 2014 Best in KLAS Software & Services report. The report ranks healthcare vendors and their solutions by the professionals who use them—healthcare providers. This year marks the first year in which 340B solution vendors were ranked as part of the annual Best in KLAS report.

The Office of Pharmacy Affairs 340B database now offers a more user-friendly experience

The Office of Pharmacy Affairs 340B database now offers a more user-friendly experience

January 6th, 2015
The Health Resources and Services Administration’s (HRSA) Office of Pharmacy Affairs (OPA) 340B database upgrade is complete, and users will find site enhancements that make it easier to navigate and use the site to register, update, and terminate covered entities, outpatient facilities and contract pharmacies.

What does HRSA’s withdrawal of the 340B mega-reg really mean?

What does HRSA’s withdrawal of the 340B mega-reg really mean?

November 21st, 2014
When it was announced last week that the Health Resources and Services Administration (HRSA) had withdrawn its long-awaited mega-reg, you may have momentarily breathed a sigh of relief. For months now, there’s been growing anxiety about what the mega-reg might address and how it might affect the 340B Program going forward. But HRSA’s latest action is not so much the end of the story as it is the start of a new chapter.

About

SentryDS.com is your source for all news and events related to healthcare information technology, Sentry Data Systems and its products.

Contributors

Travis Leonardi, RPh., C.P.
President, CEO
William D. Kirsh DO, MPH
Chief Medical Officer
Lidia Rodriguez-Hupp
SVP and 340B Compliance Officer
Dawn C. DeAngelo
Chief Pharmacy Officer

Archive